文献速递淋巴瘤

脑脊液流式细胞术检测白血病原始细胞可预测儿童急性淋巴细胞白血病复发风险:北欧儿童血液肿瘤学会研究

Flow cytometric detection of leukemic blasts in cerebrospinal fluid predicts risk of relapse in childhood acute lymphoblastic leukemia: a Nordic Society of Pediatric Hematology and Oncology study.
PubMed 文献 · Leukemia · 2019-09-18

该前瞻性队列研究纳入按北欧ALL2008方案治疗的673例儿童ALL患者,在诊断时用流式细胞术检测脑脊液。Cox回归显示CNS联合阳性是复发的独立预测因素(HR 2.2,95%CI 1.0-4.7,P=0.042)。

要点

  • 脑脊液流式细胞术可提高中枢神经系统白血病检出率。
  • 流式阳性者4年累积复发率16.5%,阴性者5.6%。
  • CNS联合阳性是复发的独立预测因素,HR 2.2。

核心结论

  • 脑脊液流式细胞术可改善中枢神经系统白血病的检测,区分高和低复发风险患者,可能改进未来风险分层和中枢神经系统导向治疗。

研究设计与样本

  • 前瞻性队列研究,纳入按北欧儿童血液肿瘤学会ALL2008方案治疗的1.0-17.9岁儿童ALL患者,来自17个中心,脑脊液样本用Transfix®保存后集中实验室流式检测。

主要发现

  • 细胞离心阳性者4年累积复发率17.1% vs 7.5%,流式阳性者16.5% vs 5.6%,两者联合阳性者16.7% vs 5.1%。
  • Cox回归(按免疫表型和29天微小残留病分层,校正性别)显示复发预测因素包括年龄(HR 1.1,95%CI 1.1-1.2,P<0.001)、诊断时白细胞计数(HR 1.4,95%CI 1.1-1.6,P<0.001)和CNS联合阳性(HR 2.2,95%CI 1.0-4.7,P=0.042)。

临床怎么用

  • 诊断时脑脊液流式细胞术检测可辅助识别高复发风险儿童ALL患者,可能指导风险分层和中枢神经系统导向治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

Central nervous system (CNS) involvement by cytospin is associated with increased risk of relapse in childhood acute lymphoblastic leukemia. We investigated if flow cytometric analysis of cerebrospinal fluid (CSF) at diagnosis improves the prediction of relapse. This prospective cohort study included patients (1.0-17.9 years) treated according to the Nordic Society of Pediatric Hematology and Oncology ALL2008 protocol. CSF flow cytometry samples were obtained at 17 centers, preserved with Transfix®, and analyzed at a central laboratory. One-hundred and seventy-one (25.4%) of 673 patients were positive by flow cytometry (CNSflow+). The 4-year cumulative incidence of relapse was higher for patients with cytospin positivity (CNScyto+) (17.1% vs. 7.5%), CNSflow+ (16.5% vs. 5.6%), and cytospin and/or flow positivity (CNScomb+) (16.7% vs. 5.1%). In Cox regression analysis stratified by immunophenotype and minimal residual disease day 29 and adjusted by sex, predictors of relapse were age (hazard ratio [HR] 1.1, 95% CI 1.1-1.2, P < 0.001), white blood cell count at diagnosis (HR 1.4, 95% CI 1.1-1.6, P < 0.001), and CNScomb+ (HR 2.2, 95% CI 1.0-4.7, P = 0.042). Flow cytometric analysis of CSF improves detection of CNS leukemia, distinguishes patients with high and low risk of relapse, and may improve future risk stratification and CNS-directed therapy.

来源:Leukemia,查看原文。版权归原作者所有。

引用

  1. Thastrup M, Marquart HV, Levinsen M, et al. Flow cytometric detection of leukemic blasts in cerebrospinal fluid predicts risk of relapse in childhood acute lymphoblastic leukemia: a Nordic Society of Pediatric Hematology and Oncology study. Leukemia. 2019. PMID: 31534171. doi:10.1038/s41375-019-0570-1

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。